Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TPD52 |
| Upstream (Parents) |
|---|
| (<<) ATAD2 → TPD52 |
| (<<) ESRP1 → TPD52 |
| (<<) CCNE2 → TPD52 |
| (<<) ECM2 → TPD52 |
| (<<) TMPRSS2 → TPD52 |
| (<<) YWHAZ → TPD52 |
| Downstream (Children) |
|---|
| TPD52 → ATAD2 (>>) |
| TPD52 → SI (>>) |
| TPD52 → HOXB13 (>>) |
| TPD52 → NKX2-1 (>>) |
| TPD52 → RIBC2 (>>) |
| TPD52 → SFTPA2 (>>) |
| TPD52 → EGF (>>) |
| TPD52 → TGFA (>>) |
| TPD52 → SPRED2 (>>) |
| TPD52 → OSGIN2 (>>) |
| TPD52 → TAF4 (>>) |
| TPD52 → PDE5A (>>) |
| TPD52 → HAP1 (>>) |
| TPD52 → SQLE (>>) |
| TPD52 → TMPRSS2 (>>) |
| TPD52 → MATK (>>) |
| TPD52 → MPZL2 (>>) |
| TPD52 → CXADR (>>) |
| TPD52 → SNX16 (>>) |
